Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice

Journal of Virology

Volumn 74, Issue 17, 2000, Pages 7952-7962

  Chapman, N M ^a   Kim, K S ^a   Tracy, S ^a   Jackson, J ^a   Hofling, K ^a   Leser, J S ^a   Malone, J ^a   Kolbeck, P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; IMMUNOGLOBULIN G1; INTERLEUKIN 4; SECRETORY PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; GENETIC TRANSFECTION; HELA CELL; IMMUNOGLOBULIN PRODUCTION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; ENTEROVIRUS B, HUMAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELA CELLS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033869701     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.17.7952-7962.2000     Document Type: Article

References (74)

1. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid
2. Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV (smm) PBj14
3. Engineering poliovirus as a vaccine vector for the expression of diverse antigens
4. Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses
5. Chimeric rhinoviruses as tools for vaccine development and characterization of protein epitopes
6. Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin 2
7. Secondary enterovirus infection in the murine model of myocarditis: Pathologic and immunologic aspects
8. Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s)
9. Evidence for a group-specific enteroviral antigen(s) recognized by human T cells
10. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
11. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses
12. IL4 prevents insulitis and insulin dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper 2 cell function
13. Purification of the putative coxsackievirus B receptor from HeLa cells
14. Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: Regulation in response to cell density
15. Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3
16. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: Its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses
17. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells
18. Addition of a foreign oligopeptide to the major capsid protein of poliovirus
19. Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: Stimulation of humoral, mucosal, and cellular immunity
20. Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1
21. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A
22. An engineered poliovirus chimaera elicits broadly reactive HIV1 neutralizing antibodies
23. Characterization of the antibody response in vaccinated mice protected against coxsackievirus B3 induced myocarditis
24. Re-examination and further development of a precise and rapid dye method for measuring cell growth/ cell kill
25. Determinants of substrate recognition by poliovirus 2A proteinase
26. Expression of the antigenic adenovirus type 2 hexon protein L1 loop region in a group B coxsackievirus
27. Three-dimensional structure of poliovirus at 2.9 angstrom resolution
28. Cellular immune mechanisms in coxsackievirus group B, type 3 induced myocarditis in Balb/C mice
29. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3
30. An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16
31. Trans-Encapsidation of a poliovirus replicon by different picornavirus capsid proteins
32. Cytokines in murine lyme carditis: Th1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain
33. The primary viruses of myocarditis
34. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast cell-stimulating activities
37. Immunogenicity and antigenicity of chimeric picornaviruses which express hepatitis A virus (HAV) peptide sequences: Evidence for a neutralization domain near the amino terminus of VP1 of HAV
38. Poliovirus vaccine vectors elicit antigenic specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen
39. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice
40. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D
41. Attenuated poliovirus strain as a live vector: Expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses
42. Antigenic structure of chimeras of type 1 and type 3 polioviruses involving antigenic sites 2, 3 and 4
43. The expanding universe of T cell subsets: Th1, Th2 and more
44. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins
45. Expression of foreign proteins by poliovirus polyprotein fusion: Analysis of genetic stability reveals rapid deletions and formation of cardioviruslike open reading frames
46. Poliovirus antigenic hybrids simultaneously expressing antigenic determinants from all three serotypes
47. Treatment of experimental viral myocarditis with interleukin 10
48. Coupling between genome translation and replication in an RNA virus
49. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response
50. Functional coupling between replication and packaging of poliovirus replicon RNA
51. Role of cytokines in determining T lymphocyte function
52. Proteolytic processing of picornaviral polyprotein
53. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection
54. Multiple forms of recombinant murine interleukin-4 expressed in COS-7 monkey kidney cells
55. Coxsackievirus and pancreatitis
56. Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigen chimera
57. The construction and characterization of poliovirus antigen chimeras presenting defined regions of the human T lymphocyte marker CD4
58. Genetics of susceptibility to viral myocarditis in mice
59. Structure of a human common cold virus and functional relationship to other picornaviruses
60. Virus encoded proteinases of the picornavirus supergroup
61. On the size of the active site in proteases
62. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3
63. Substrate requirements of a human rhinoviral 2A proteinase
64. IL4 directs the development of Th2 like helper effectors
65. Toward a poliovirus-based simian immunodeficiency virus vaccine: Correlation between genetic stability and immunogenicity
66. Infectious Th1 and Th2 autoimmunity in diabetes prone mice
67. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
68. Group B coxsackievirus myocarditis and pancreatitis in mice: Connection between viral virulence phenotypes
69. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region
70. Recognition of poliovirus/HIV chimaeras by antisera from individuals with HIV infection
71. Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice
72. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities
73. A disulfidebound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1